How to Actually Use the Deloitte Painkiller Framework Without Losing Your Mind

Most people who stumble onto this don't realize they're already thinking about it. The Deloitte Painkiller Case Study is less a formal document and more a way of framing problems that Deloitte built into their consulting methodology. It's the "painkiller versus vitamin" distinction, dressed up in a framework and applied across industries. If you've ever been in a strategy meeting where someone asked "is this a painkiller or a vitamin," you've already encountered it.

What the Deloitte Painkiller Case Study Actually Is

At its core, the framework asks you to categorize a proposed solution based on whether it addresses an acute, urgent problem (a painkiller) or a nice-to-have improvement (a vitamin). Deloitte extended this into a full case study method where teams evaluate digital transformations, product launches, and business model changes through this lens. The idea is straightforward — organizations fund painkillers faster than vitamins because the ROI is visible and immediate. Here's what beginners consistently mess up. They treat this as a binary checkbox exercise. It isn't. In my experience, the most useful application is when you're trying to justify budget for something that sits in the gray area between the two categories. A feature might be a vitamin today but become a painkiller tomorrow if market conditions shift. The case study approach forces you to articulate that timeline rather than pretending the classification is permanent. I spent roughly three weeks last year working through a Deloitte Painkiller Case Study exercise for a mid-market SaaS company that wanted to pivot toward enterprise. The product team had spent months building what they considered a must-have analytics dashboard. When we ran it through the framework, it came out squarely as a vitamin — useful, but not urgent enough for enterprise buyers to pull the trigger. That was a hard conversation to have. The workaround I used was to reframe the dashboard as a compliance requirement. Several of their target accounts were facing new regulatory reporting deadlines within six months. Once I mapped the feature to an actual regulatory pain point, it shifted from vitamin to painkiller territory overnight. The case study didn't change. The context around it did.

The Practical Method

Start by listing every feature, initiative, or proposed solution you want to evaluate. Don't group them. Don't prioritize them yet. Just get them on the page. Then for each one, ask two questions: what problem does this solve, and how urgent is that problem to the customer right now? If the problem is something the customer is actively losing money on, struggling with daily, or facing regulatory pressure around, it's a painkiller. If it's something that would make their life marginally better or more efficient, it's a vitamin. Most initiatives fall into one of these two buckets. A small number sit in transition — they're vitamins that are on track to become painkillers, or painkillers that are losing urgency. The case study portion of this comes when you document the evidence for your classification. Not your opinion. Evidence. Customer interviews, churn data, sales cycle length, support ticket volume related to the problem. I've seen teams skip this step and just declare something a painkiller because leadership likes it. That defeats the entire point of the framework.

Where This Framework Actually Breaks Down

The biggest limitation is timing. Painkiller status is not static. A solution that registers as a painkiller today might be tabled six months later because the market moved or a competitor solved it first. I ran into this with a client who classified their cybersecurity monitoring tool as a painkiller in Q1. By Q3, a well-funded startup had shipped a superior solution at half the price, and what used to be an urgent problem became a commodity. Our case study had been accurate at the time it was written. It just wasn't durable. Another issue is that the framework doesn't account for strategic bets. Sometimes you build a vitamin because you know it will become essential later. Cloud infrastructure was a vitamin when companies started migrating. Now it's infrastructure — meaning it's a painkiller if you don't have it. The Deloitte Painkiller Case Study approach won't flag those investments unless you bring external market intelligence to the exercise. You have to supplement the framework with scenario planning, which is a separate discipline entirely. There's also the internal politics problem. Departments that own vitamin-classified initiatives often push back aggressively. They'll argue that the framework undervalues their work, and sometimes they're right. Strategic platforms, brand building, employee experience tools — these don't score well on painkiller metrics but they matter. The framework is diagnostic, not prescriptive. It tells you where something lands, not whether it should exist.

How to Get Started

If you want to run a Deloitte Painkiller Case Study exercise yourself, you don't need a consultant. Grab a spreadsheet and set up four columns: initiative name, problem statement, customer urgency evidence, and classification with rationale. Pick three to five initiatives you're currently debating. Fill in the columns honestly. If you can't find evidence for the urgency, that's data in itself — it means the classification might be wishful thinking. Several consulting firm websites host simplified versions of this framework as downloadable templates. Deloitte's own resources around digital transformation include variations of this thinking, though they rarely package it under the exact name "Painkiller Case Study." You'll find more practical sheets from independent business strategy communities and platforms like the Strategyzer website, which offers a related value proposition canvas that overlaps significantly. The exercise usually takes two to three hours for a small team if you're disciplined about it. The real value shows up in the follow-up — when you're back in budget meetings and someone asks why Initiative X got funding over Initiative Y, you have evidence rather than intuition to fall back on. That alone makes the framework worth the effort, even if the classification turns out to be wrong. It forces you to articulate why you think what you think, which is something most strategy work skips entirely.